INTERNATIONAL PATENT: GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. FILES APPLICATION FOR "USE OF DUAL-TARGET CAR-T CELLS IN TREATING B-CELL AUTOIMMUNE DISEASES"

GENEVA, Feb. 15 -- GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. (Floor 12, Building 1, No. 926 Yishan RoadXuhui District, Shanghai 200233) filed a patent application (PCT/CN2024/110892) for "USE OF DUAL-TARGET CAR-T CELLS IN TREATING B-CELL AUTOIMMUNE DISEASES" on Aug 09, 2024. With publication no. WO/2025/031469, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHI, Huan (Floor 12, Building 1, No. 926 Yishan RoadXuhui District, Shanghai 200233), SHEN, Lianjun (Floor 12, Building 1, No. 926 Yishan RoadXuhui District, Shang...